SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-20-021998
Filing Date
2020-10-29
Accepted
2020-10-29 16:25:47
Documents
15
Effectiveness Date
2020-10-29

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A kmph20201029_defa14a.htm DEFA14A 33703
2 slide01.jpg GRAPHIC 28585
3 slide02.jpg GRAPHIC 132942
4 slide03.jpg GRAPHIC 30610
5 slide04.jpg GRAPHIC 95413
6 slide05.jpg GRAPHIC 70616
7 slide06.jpg GRAPHIC 74461
8 slide07.jpg GRAPHIC 88654
9 slide08.jpg GRAPHIC 88958
10 slide09.jpg GRAPHIC 95383
11 slide10.jpg GRAPHIC 84844
12 slide11.jpg GRAPHIC 75884
13 slide12.jpg GRAPHIC 84772
14 slide13.jpg GRAPHIC 85337
15 slide14.jpg GRAPHIC 28585
  Complete submission text file 0001437749-20-021998.txt   1500924
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 201272998
SIC: 2834 Pharmaceutical Preparations